Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$.27 would be a 1Myle High and Cryptonite Blastoff! Looking forward to it.
Whatever it was, more next week would be nice! Hopefully the stock price goes 1Myle High!
I don't remember the year, but it was awhile ago. Then they tried the name DECENTRAFIN for a while as well and even had a website. That one went defunct also. Then it was on to working with PlutusX. Perhaps Devvio will stick with ADTM this time around!
Read these PRs from FEB-APR showing cancer treatment patent, collaboration with University of Georgia, successful initial covid mice study, and increased financing to bring all to market.
https://sunshinebiopharma.com/press-release-archives/
How about $2's if they succeed on both COVID and CANCER pills?
Maybe he will buy some DevvE Tokens and help ADTM move to pennies!
DevvE plans to replace BITCOIN...see DevvESG info at website link below:
https://www.devv.io/environmental-social-governance
Here is a great DEVVIO Interview...great info on the past, present and future of DEVVIO. Not sure if DEVVIO will reverse merge into ADTM, but Strong is an advisor for DEVVIO. We'll probably find out in the coming weeks/months...enjoy interview if you haven't seen it yet.
DEVVIO Interview link: https://www.steverichfx.com/devvio-the-top-ten-blockchain-you-havent-even-heard-of-yet-the-fastest-blockchain-in-the-world/
Agree and pumped up by NEWS this week...anything that helps treat cancer, covid and general health will be in high demand for the foreseeable future.
That could be a clue to something real in the future, but such silence and secrecy after the many announcements and dead ends in 2018-2019 is difficult to understand....except perhaps that Mr. Strong learned that announcing stuff too early is not good either. He claimed to have $50M funding at one point and that he was going into the crypto-cannabis market, but that did not happen.
So, I could have sold all my shares in the run to .002+, but did not. I am interested in the Wyoming and Devvio connections and await the future!
Yes, they should know know by now how the mice did with the treatment. At least a preliminary update.
If they are still waiting for the up-tier to OTCQB before giving a mice update, then getting both updates in the next couple of weeks should greatly boost the share price.
I have been here several years. Mr. Strong was very talkative in 2018-2019 then went silent on ADTM. Remember his talk about ADTM becoming Perfect Circle and Decentrafin? Sure, the ADTM website came back to life, but it largely reflects what it was years ago and no real new info. The ADTM website homepage talks about a Coin and Media Graph, but none of that makes sense when you click on the links. Media Graph even goes to a website that doesn't seem connected to ADTM (see link below). And I don't see an Adaptive Media Coin on the Bitcoin Pro Platform where it is purported to be.
So, what makes ATDM GOOD? The only thing I can say is it the price is a lot higher than .0001 that it was at for much of the past 2 years.
Media Graph: https://www.media-graph.com/
Good luck. I still have some shares from the .0001-.0002 price point, but have a hard time seeing this get much over .002 again unless the Devvio connection becomes a merger. However, this seems doubtful based on all the speculation about PlutusX for the past 2 years (that seems to have gone bust) and the prior attempt to turn ADTM into a crypto company call Decentrafin.
Here's the AXXA, RIOT, MARA article...we need to find out how many BITCOIN AXXA has.
https://www.streetinsider.com/OTC+PR+Wire/Bitcoin+to+%24400k%3F+Outlook+from+Fin+Leader+Drives+Crypto+Stocks+%28NASDAQ%3A+RIOT%29+%28OTC+US%3A+HVBTF%29+%28OTC+US%3A+AXXA%29+%28NASDAQ%3A+MARA%29/18259274.html
If ADTM GOOD, why is Mr. Strong silent for so long?
And COVID treatment is here to stay despite the vaccine roll-out. Can't wait for the mice results and then FDA fast-track to human trials.
Sure, I'll take it - .055 to .40 on Monday!
Interesting and nice price jump EOD! Back to $.08 next week?
Well, I had a daydream today and it was..................
Mice studies went very well and the FDA decided to put the SBFM Covid Pill on the fast track. We'll see if my daydream comes true!
Yes, let's take those mice to market...I mean the Covid pill they are eating. I see that RB Capital (Brett Rosen) is investing more!
$5 first, then $50!
Patents, OTCQB, UoG studies, healthy mice, Covid pill, Cancer treatment, etc. = Dollars!
Did you mean UPLIFTING NEWS? OTCQB and/or Mice NEWS?
Time to prep for some upticking this week?
Just looking for public marketing of 1MYLE. Need to show more presence of this AXXA subsidiary. Tweeting is fine, but needs to be accompanied by the NEWS and marketing. I'm assuming the new MMC will do it, but needs to happen sooner than later.
Yes, AXXA needs to stop tweeting and start marketing 1MYLE...PRs, a website and Banner Ads to start.
Yes, time for some 1MYLE Crypto Exchange marketing.
SBFM has US and EU patents and planned trials for cancer treatment....
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
Press Release | 03/11/2021
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has received a “Notice of Allowance” from the European Patent Office for a new patent application covering Adva-27a, the Company’s flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Europe until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The Canadian Intellectual Property recently issued a Notice of Allowance for the analogous patent in Canada. Sunshine Biopharma is the sole owner of all intellectual property rights pertaining to Adva-27a, including the first Adva-27a patent issued in the United States in 2012 (US Patent Number 8,236,935).
“We are very excited about this significant extension of proprietary protection for Adva-27a,” said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma. “With a total population of nearly 450 million people, the European Union represents a significant market for Adva-27a once approved for marketing,” he added.
About Sunshine Biopharma’s Adva-27a
Adva-27a is a unique anticancer compound targeted for multidrug resistant cancer. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University’s Jewish General Hospital in Montreal, Canada.
That's the plan with UoG Scientists backing them up...
Sunshine Biopharma Initiates COVID-19 Treatment Mice Study
Press Release | 02/10/2021
MONTREAL, QC / ACCESSWIRE / February 10, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has initiated a momentous transgenic mice study of its COVID-19 treatment that has been under development since May of last year. Sunshine Biopharma's COVID-19 treatment consists of a series of small molecules which suppress replication of the virus by inhibiting a key virus encoded protease that is responsible for compromising the immune system of infected patients. The mice studies are currently underway at the University of Georgia, College of Pharmacy.
The mice being used in the study have been genetically engineered to express the human angiotensin-converting enzyme 2 (hACE2) transmembrane protein in their lungs making them susceptible to lethal infection by SARS-CoV-2, the causative agent of COVID-19. The SARS-CoV-2 virus uses the hACE2 receptor to gain entry into human cells to replicate. The goal of the study is to determine if Sunshine Biopharma's protease inhibitors will protect the hACE2-transgenic mice from disease progression and death following infection with SARS-CoV-2 virus.
"Should these mice studies prove successful, we plan to submit the results to the FDA for authorization to conduct testing on actual COVID-19 patient volunteers in a Phase I clinical trial setting," said Dr. Steve Slilaty, CEO of Sunshine Biopharma. "We are excited to have initiated this pivotal study on transgenic mice with the University of Georgia. The implications of a COVID-19 treatment becoming available are vast. This is particularly the case in view of the fact that some of the variants emerging around the world are more virulent and may escape neutralization by the current vaccines," he added.
Yes, and if the SBFM mice do well with their COVID treatment, that will help SBFM get bought out for a high premium!
Also, AXXA SUXXA NOWSA, but AXXA GOSA UPSA SOONSA (IMO)! GOOD LUXXA!
I said that 10 years ago, but still here. I can't give it up despite the ups and downs!
I think the next significant move upward is dependent on their next 1Myle announcement. Should be anytime now, but they need to talk it up to include a web presence and more about how much revenue it will bring in based on the European marketplace deal they have. Until then, I think AXXA floats between 6-8 cents.
If that is how it works, are you going to sell so we can get to dollars? If so, thanks! Just kidding, hoping we all get some dollars out this one.
Sounds good. Anytime in April!
I am vaccinated, but I still want the Sunshine Pill for all those that are not getting vaccinated and all the variants that we are seeing now and in the future! I am a fan of taking pills for treatment as much as getting a vaccine when available.
How about a Tier Uplist this week and a Mouse Alive party by the end of April!
How about $.15 this week and $.30 by the end of April and then $2.00 by the end of 2021!
AXXA 1Myle Bitcoin volume to see substantial growth soon....
Exxegroup @exxegroup Mar 19
$AXXA 1Myle's just received confirmation that the paperwork to connect to a major #European #BTC #Liquidity #marketplace has been finalized. It means our #Bitcoin #volume will see a substantial #Growth. More details to come in official releases. $AXXA
Also waiting patiently for 1MYLE LTD to become more publicly visible. Perhaps MMC will help make that happen within days/weeks.
From the recent MMC PR:
"One of the strategies underpinning the acquisition decision was to utilize MMC to accelerate brand recognition technologies across AXXA's various asset classes. This includes enhancing 1Myle's client acquisition target plan by increasing 1Myle brand profile as a trusted operator in Bitcoin and crypto exchange services.
Holding tight waiting for the 1Myle crypto blastoff!
Great. I'll be content with anything from $1 to $17 in 2021!